Dow Up1.63% Nasdaq Up0.97%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
7.88 Down 0.51(6.08%) Oct 17, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents32,980  40,302  48,789  
Short Term Investments49,211  48,206   -  
Net Receivables5,537  675   -  
Inventory7,152  1,152   -  
Other Current Assets2,281  1,127  610  
Total Current Assets 97,161   91,462   49,399  
Long Term Investments8,756   -   -  
Property Plant and Equipment2,554  1,421  1,310  
Goodwill -   -   -  
Intangible Assets1,158  683  912  
Accumulated Amortization -   -   -  
Other Assets361  334  55  
Deferred Long Term Asset Charges1,005  89  2,054  
Total Assets 110,995   93,989   53,730  
Liabilities
Current Liabilities
Accounts Payable18,314  10,666  11,763  
Short/Current Long Term Debt -  11,809  6,775  
Other Current Liabilities8,086  508  232  
Total Current Liabilities 26,400   22,983   18,770  
Long Term Debt47,037  11,339  22,711  
Other Liabilities2,677  1,788  2,341  
Deferred Long Term Liability Charges1,417  309  465  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 77,531   36,419   44,287  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -  49  
Common Stock40  31  2  
Retained Earnings(178,528)(86,255)(39,971)
Treasury Stock -   -   -  
Capital Surplus211,952  143,851  49,362  
Other Stockholder Equity -  (57)1  
Total Stockholder Equity 33,464   57,570   9,443  
Net Tangible Assets 32,306   56,887   8,531  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.